Dow Today: E.I. Du Pont De Nemours & Company (DD) Higher

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

The Dow Jones Industrial Average ( ^DJI) is trading up 62 points (+0.5%) at 13,601 as of Friday, Sep 14, 2012, 12:40 p.m. ET. During this time, 541.6 million shares of the 30 Dow components have changed hands vs. an average daily trading volume of 581.5 million. The NYSE advances/declines ratio sits at 2,210 issues advancing vs. 754 declining with 119 unchanged.
  • ACTIVE STOCK TRADERS: Get full access to Jim Cramer's thoughts for less than $3/week - sometimes before he says them on TV! Start with a 14-Day Free Trial.

The Dow component leading the way higher looks to be E.I. du Pont de Nemours & Company (NYSE: DD), which is sporting a $1 gain (+2%) bringing the stock to $52.13. This single gain is lifting the Dow Jones Industrial Average by 7.57 points or roughly accounting for 12.2% of the Dow's overall gain. Volume for E.I. du Pont de Nemours & Company currently sits at 4.4 million shares traded vs. an average daily trading volume of 4.6 million shares.

E.I. du Pont de Nemours & Company has a market cap of $46.73 billion and is part of the basic materials sector and chemicals industry. Shares are up 11.7% year to date as of Thursday's close. The stock's dividend yield sits at 3.4%.

E. I. du Pont de Nemours and Company operates as a science and technology based company worldwide. Its Agriculture segment provides hybrid corn and soybean seeds, and grains under the Pioneer brand name; and herbicides, fungicides, and insecticides. The company has a P/E ratio of 13.6, equal to the average chemicals industry P/E ratio and below the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates E.I. du Pont de Nemours & Company as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity, expanding profit margins and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had sub par growth in net income.

FREE from Real Money's Jim Cramer: Winners and Losers Election 2012 - Steps to take NOW so you can profit no matter who is in charge! Free download now.
null

If you liked this article you might like

Why Bayer's $66 Billion Takeover of Monsanto Probably Won't Happen Until 2018

DowDupont Closes Higher in First Day of Trading, Company Still Faces Challenges

Apple Is the Tom Brady of Stocks: Cramer's 'Mad Money' Recap (Thursday 8/31/17)

FMC Stock's Impressive Rally Has Another 20% to Gain: Jim Cramer

Jim Cramer on Why FMC Was Upgraded by Bank of America